does medicare cover any glp 1 drugs medication 🚨 Medicare GLP-1 Update 🚨 Starting July 2026 CMS Issues Coverage Guidance on

[24]S.A

THE FIT PROGRAM INCLUDED ADULT PATIENTS WITH CHRONIC ITP WHO HAD RECEIVED 1 PRIOR THERAPY FIT program patients were representative of the general adult chronic ITP population, including exposure to prior therapies TAVALISSE dosing 3 Starting dose of TAVALISSE: One 100 mg tablet BID Based on platelet count and tolerability, the dose could be increased to one 150 mg tablet BID at or after week 4 Patients who had a platelet count 50 x 10 9 /L at the time of rollover to the FIT-3 open-label extension study maintained their existing dose of TAVALISSE References: 1

Treschan TA, Peters J (2006) The vasopressin system: physiology and clinical strategies

However, barring further research, this remains a speculatory point [11]

possible lower claims costs from chronic health conditions